KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Feb 20, 2019 $128.51 $130.42 $128.45 $129.84 1 758 158
Feb 19, 2019 $128.48 $129.78 $128.05 $128.93 1 169 679
Feb 15, 2019 $125.44 $129.49 $125.44 $129.42 1 299 915
Feb 14, 2019 $124.73 $126.23 $123.94 $125.93 1 017 026
Feb 13, 2019 $125.00 $125.30 $123.21 $125.18 1 160 511
Feb 12, 2019 $121.70 $124.37 $121.43 $124.26 1 701 834
Feb 11, 2019 $120.76 $121.40 $119.29 $120.05 969 076
Feb 08, 2019 $118.03 $120.19 $117.80 $120.14 1 057 608
Feb 07, 2019 $119.57 $120.37 $117.31 $118.79 1 479 412
Feb 06, 2019 $122.72 $123.10 $120.94 $121.03 1 556 601
Feb 05, 2019 $123.39 $124.88 $121.56 $122.87 1 889 051
Feb 04, 2019 $128.67 $129.00 $121.43 $123.75 3 629 816
Feb 01, 2019 $124.44 $126.51 $123.15 $126.28 2 470 357
Jan 31, 2019 $121.41 $123.21 $120.44 $122.96 1 678 082
Jan 30, 2019 $119.62 $121.65 $117.66 $121.32 1 427 945
Jan 29, 2019 $119.32 $119.99 $117.12 $119.61 2 276 474
Jan 28, 2019 $119.87 $120.01 $117.00 $119.21 2 012 087
Jan 25, 2019 $118.98 $121.59 $118.37 $121.44 1 501 610
Jan 24, 2019 $117.25 $117.98 $116.38 $117.91 1 557 372
Jan 23, 2019 $115.14 $117.98 $114.83 $117.00 2 480 505
Jan 22, 2019 $115.28 $115.32 $112.14 $114.29 2 841 642
Jan 18, 2019 $115.70 $117.37 $113.54 $117.05 2 528 349
Jan 17, 2019 $111.62 $115.65 $111.10 $114.62 1 926 632
Jan 16, 2019 $111.89 $113.99 $110.81 $111.70 2 158 053
Jan 15, 2019 $108.17 $111.77 $107.76 $111.73 1 949 308
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT